Truist Securities Maintains Buy on SI-BONE, Lowers Price Target to $20

Benzinga Newsdesk www.benzinga.com Neutral 52.1%

Neg 0% Neu 52.1% Pos 0%

Truist Securities analyst Samuel Brodovsky maintains SI-BONE (NASDAQ:SIBN) with a Buy and lowers the price target from $24 to $20.